• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

drug design

Cooked spaghetti in a white ceramic bowl next to uncooked spaghetti on white painted wood
Research

Controlled chaos: New method can design disordered proteins

Scientists have created a method to design disordered proteins with specific biologically relevant properties, which could lead to new therapeutics.
Darren Incorvaia Aug 28, 2024 2:00pm
exterior shot of the headquarters office of Verily Life Sciences

Verily links up with Sosei Heptares for GPCR drug discovery

Jan 6, 2022 3:30pm
Prescription drugs

Insilico, 4B Technologies team up for ALS drug discovery

Aug 27, 2021 9:55am
molecule

AI drug miner XtalPi strikes gold with $400M VC infusion

Aug 13, 2021 11:26am
molecule

Exscientia scores $225M with access to another $300M

Apr 28, 2021 10:17am
BigHat Biosciences founders Mark DePristo CEO and Peyton Greenside CSO

BigHat bags $19M to 'supercharge' antibody development

Feb 10, 2021 8:00am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings